Takeda Pharmaceutical Li...

OTC: TKPHF · Real-Time Price · USD
29.45
0.00 (0.00%)
At close: Aug 13, 2025, 11:10 AM
29.45
0.00%
After-hours: Aug 13, 2025, 08:00 PM EDT

Takeda Pharmaceutical Balance Sheet Statement

Financials in JPY. Fiscal year is April - March.
Fiscal Year Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020
Cash & Equivalents
350.01B 385.11B 494.13B 859.01B 804.27B 205.19B 288.36B 318.05B 316.38B 533.53B 685.14B 798.14B 645.99B 849.7B 724.34B 607.88B 654.92B 966.22B 617.63B 630.87B 589.79B
Short-Term Investments
69.17B 20.48B 32.62B 47.2B 359.49B 252.61B 29.05B 15.76B 52.23B 20.17B 41.47B 31.93B 18.54B 25.3B 27.55B 25.74B 29.93B 36.6B 36.66B 15.31B 11.14B
Long-Term Investments
347.12B 361.93B 410.21B 277.31B 87.69B 430.61B 372.92B 416.36B 393.53B 378.86B 369.47B 425.77B 381.61B 330.13B 334.81B 352.09B 374.66B 348.35B 376.05B 349.6B 336.64B
Other Long-Term Assets
68.56B 70.28B 74.16B 85.02B 847.22B 51.21B 54.7B 59.67B 60.14B 63.33B 66.77B 80.7B 84.68B 82.61B 79.64B 94.29B 95.02B 100.34B 96.57B 100.23B 103.02B
Receivables
679.53B 725.25B 735.06B 721.06B 755.42B 697.61B 716.23B 755.33B 792.89B 681.69B 707.32B 759.89B 762.13B 724.38B 715.51B 843.63B 827.25B 812.71B 791.48B 753.99B 784.64B
Inventory
1,240.7B 1,217.3B 1,246.4B 1,206.4B 1,276.7B 1,209.9B 1,169.6B 1,155.9B 1,083.4B 986.46B 927.29B 953.45B 927.51B 853.17B 811.32B 783.48B 779.15B 753.88B 739.35B 743.48B 759.38B
Other Current Assets
173.74B 173B 246.05B 220.31B 271.1B 278.47B 254.6B 232.82B 279.37B 302.54B 276.2B 234.13B 213.89B 273.26B 226.71B 221.37B 215.14B 285.3B 468.13B 456.8B 340.96B
Total Current Assets
2,513.1B 2,521.2B 2,754.3B 3,054B 3,107.5B 2,558.6B 2,428.8B 2,462.1B 2,472B 2,398B 2,595.9B 2,745.6B 2,549.5B 2,593.6B 2,477.9B 2,456.4B 2,476.5B 2,712.9B 2,616.6B 2,585.1B 2,474.8B
Property-Plant & Equipment
1,956.3B 1,968.2B 2,017.8B 1,887.6B 2,085.4B 1,989.8B 1,841.5B 1,894.1B 1,795.3B 1,691.2B 1,656.4B 1,760.3B 1,705.4B 1,582.8B 1,493.6B 1,459.9B 1,452.2B 1,453.9B 1,363.1B 1,367B 1,366.2B
Goodwill & Intangibles
8,718.4B 8,956B 9,474.2B 8,930.7B 10,099.9B 9,684.8B 9,208.3B 9,703.4B 9,696.2B 9,060.4B 8,456.7B 9,181.7B 8,958.7B 8,226.3B 7,959.9B 7,862B 7,915.4B 7,943B 7,581.5B 7,734.4B 8,027.4B
Total Long-Term Assets
11,491.4B 11,727.2B 12,352.6B 11,519B 13,120.2B 12,550.2B 11,794.1B 12,409.8B 12,320.7B 11,559.8B 10,908.8B 11,843.2B 11,515.9B 10,584.4B 10,220.6B 10,103.9B 10,180.8B 10,199.4B 9,669.5B 9,829.6B 10,139.1B
Total Assets
14,004.5B 14,248.3B 15,106.8B 14,573B 16,227.7B 15,108.8B 14,222.9B 14,871.9B 14,792.7B 13,957.8B 13,504.7B 14,588.8B 14,065.4B 13,178B 12,698.5B 12,560.3B 12,657.2B 12,912.3B 12,286.1B 12,414.7B 12,613.9B
Account Payables
421.31B 308.45B 460.18B 413.33B 468.88B 319.95B 483.67B 421.08B 440.92B 307.45B 381.11B 388.62B 424.36B 295.93B 351.19B 336.6B 320.64B 232.1B 326.98B 272.78B 289.74B
Deferred Revenue
n/a n/a n/a n/a n/a 109.91B 594.91B 787.88B 770.53B 740.74B 661.97B 674.31B 714.36B 644.42B 606.92B 603.14B 611.23B 616.48B 597.51B 602.28B 604.16B
Short-Term Debt
371.14B 548.94B 135.47B 624.1B 438.74B 433.46B 370.29B 274.84B 416.86B 339.6B 372.02B 568.23B 281.9B 203.99B 122.94B 214.89B 24.27B 22.15B 284.47B 276.62B 580.73B
Other Current Liabilities
1,226.2B 1,348.5B 1,342.9B 1,208.4B 1,557.6B 1,383.6B 833.3B 883.82B 873.43B 1,775.3B 821.71B 760.57B 746.33B 1,591.9B 728.21B 764.12B 750.64B 1,468.7B 596B 557.99B 556.91B
Total Current Liabilities
2,169.6B 2,506.5B 2,098B 2,387.2B 2,465.2B 2,313.1B 2,282.2B 2,367.6B 2,501.7B 2,481.9B 2,236.8B 2,391.7B 2,166.9B 2,145.7B 1,809.3B 1,918.8B 1,706.8B 1,773.2B 1,805B 1,709.7B 2,031.5B
Long-Term Debt
4,134.8B 3,966.3B 4,704.7B 4,427.1B 5,042.2B 4,476.5B 4,293.9B 4,404.4B 4,330.3B 4,042.7B 3,914.9B 4,168.4B 4,320.4B 4,141.4B 4,231.9B 4,016.5B 4,381.6B 4,613.2B 4,466.6B 4,631.4B 4,494.2B
Other Long-Term Liabilities
800.46B 804.37B 847.34B 278.87B 304.62B -61.68B 205.51B 300.07B 342.16B 450.55B 455.38B 536.05B 529.62B 576.31B 1,090.8B 1,071.1B 1,104.4B 731.2B 624.39B 684.56B 740.24B
Total Long-Term Liabilities
4,968.8B 4,805.8B 5,589.7B 5,264.2B 5,963.2B 5,521.7B 5,198.2B 5,433.2B 5,369.3B 5,121.1B 5,091.4B 5,483.6B 5,581.1B 5,348.8B 5,557.4B 5,317.2B 5,711.8B 5,961.9B 5,841.8B 6,038.6B 5,891.5B
Total Liabilities
7,138.4B 7,312.4B 7,687.7B 7,651.4B 8,428.5B 7,834.8B 7,480.3B 7,800.9B 7,871.1B 7,603.1B 7,328.2B 7,875.4B 7,748B 7,494.5B 7,366.7B 7,235.9B 7,418.6B 7,735.1B 7,646.7B 7,748.2B 7,923.1B
Total Debt
4,505.9B 4,515.3B 4,840.1B 5,051.2B 5,481B 5,463.4B 4,664.2B 4,679.2B 4,747.1B 4,382.3B 4,286.9B 4,736.6B 4,602.3B 4,345.4B 4,354.9B 4,231.4B 4,405.9B 4,635.4B 4,751B 4,908B 5,075B
Common Stock
1,694.7B 1,694.7B 1,694.7B 1,694.7B 1,676.6B 1,676.6B 1,676.5B 1,676.5B 1,676.4B 1,676.3B 1,676.3B 1,676.3B 1,676.3B 1,676.3B 1,676.3B 1,676.3B 1,669.1B 1,668.1B 1,668.1B 1,668.1B 1,668.1B
Retained Earnings
1,156.7B 1,187.6B 1,290.9B 1,431.7B 1,338.2B 1,391.2B 1,396.8B 1,446B 1,490.1B 1,541.1B 1,507.7B 1,530.2B 1,459.8B 1,479.7B 1,466.9B 1,551.2B 1,503.8B 1,509.9B 1,306.6B 1,337.1B 1,330.1B
Comprehensive Income
n/a 2,351.9B 2,701.5B 2,081.1B 3,074.7B 2,509.3B 1,989.7B 2,288B 2,112.9B 1,508.1B 1,380.2B 1,911.2B 1,602.6B 934.17B 584.27B 451.07B 425.16B 366.11B 41.55B 47.88B 87.81B
Shareholders Equity
6,865.3B 6,935.1B 7,418.3B 6,920.8B 7,798.4B 7,273.3B 6,741.9B 7,070.4B 6,921.1B 6,354.1B 6,176B 6,712.9B 6,316.8B 5,683B 5,331.3B 5,323.9B 5,238.3B 5,173B 4,635.4B 4,662.4B 4,686.8B
Total Investments
416.29B 382.4B 442.83B 324.51B 447.18B 683.22B 401.96B 432.12B 445.76B 399.03B 410.94B 457.7B 400.15B 355.44B 362.37B 377.83B 404.59B 384.95B 412.71B 364.92B 347.78B